Department of Pediatrics, Division of Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, CA, USA.
Pediatric, Adolescent and Young Adult Section, Joslin Diabetes Center, Boston, MA, USA.
Curr Diab Rep. 2022 Jul;22(7):291-299. doi: 10.1007/s11892-022-01469-w. Epub 2022 May 6.
Diabetes technology (insulin pumps, continuous glucose monitoring, automated insulin delivery systems) has advanced significantly and provides benefits to the user. This article reviews the current barriers to diabetes device adoption and sustained use, and outlines the known and potential facilitators for increasing and sustaining device adoption.
Barriers to diabetes device adoption continue to exist at the system-, provider-, and individual-level. Known facilitators to promote sustained adoption include consistent insurance coverage, support for providers and clinics, structured education and support for technology users, and device user access to support as needed (e.g., through online resources). Systemic barriers to diabetes device adoption persist while growing evidence demonstrates the increasing benefits of newest devices and systems. There are ongoing efforts to develop evidence-based structured education programs to support device adoption and sustained use.
糖尿病技术(胰岛素泵、连续血糖监测、自动胰岛素输送系统)有了显著的进步,并为使用者带来了益处。本文综述了目前糖尿病设备采用和持续使用的障碍,并概述了增加和维持设备采用的已知和潜在的促进因素。
糖尿病设备采用的障碍仍然存在于系统、提供者和个人层面。已知的促进持续采用的因素包括持续的保险覆盖、对提供者和诊所的支持、为技术使用者提供结构化的教育和支持,以及设备使用者在需要时获得支持的机会(例如,通过在线资源)。虽然越来越多的证据表明最新设备和系统的益处越来越多,但糖尿病设备采用的系统性障碍仍然存在。目前正在努力制定基于证据的结构化教育计划,以支持设备的采用和持续使用。